HEALTHDEVELOPING09/21/26
Trump Medicaid Drug Price Deals
Trump announces most-favored-nation drug pricing for Medicaid programs
DEVELOPING TIMELINE
First Report Sep 19: MFN Drug Pricing Extends to Medicaid
Sep 21: Trump reached deals with 26 pharmaceutical companies
DIFFERENT FOCUS
NPR Health emphasized Uncertain, Incomplete Implementation; Washington Examiner Healthcare emphasized Decisive Policy Win.
LEFT FOCUS
- ▸It remains unclear which specific drugs will actually be affected by the new pricing arrangements. — NPR Health
- ▸Each individual state must opt in, complicating the rollout of the promised price reductions. — NPR Health
RIGHT FOCUS
- ▸All 50 states, D.C., and Puerto Rico will benefit from the newly negotiated lower prices. — Washington Examiner Healthcare
- ▸Trump said the deals will save states "billions and billions of dollars per year" on drugs. — Washington Examiner Healthcare
- ▸Savings are expected to let states invest in better healthcare and higher quality services. — Washington Examiner Healthcare